Ilieș, M.; Uifălean, A.; Pașca, S.; Dhople, V.M.; Lalk, M.; Iuga, C.A.; Hammer, E.
From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells. J. Pers. Med. 2020, 10, 292.
https://doi.org/10.3390/jpm10040292
AMA Style
Ilieș M, Uifălean A, Pașca S, Dhople VM, Lalk M, Iuga CA, Hammer E.
From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells. Journal of Personalized Medicine. 2020; 10(4):292.
https://doi.org/10.3390/jpm10040292
Chicago/Turabian Style
Ilieș, Maria, Alina Uifălean, Sergiu Pașca, Vishnu Mukund Dhople, Michael Lalk, Cristina Adela Iuga, and Elke Hammer.
2020. "From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells" Journal of Personalized Medicine 10, no. 4: 292.
https://doi.org/10.3390/jpm10040292
APA Style
Ilieș, M., Uifălean, A., Pașca, S., Dhople, V. M., Lalk, M., Iuga, C. A., & Hammer, E.
(2020). From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells. Journal of Personalized Medicine, 10(4), 292.
https://doi.org/10.3390/jpm10040292